Budamate 400 Transhaler for COPD — Is It Effective for Reducing Exacerbations?

[henrywhite9]

My pulmonologist prescribed Budamate 400 Transhaler for my moderate-to-severe COPD after two hospitalizations last year. The budesonide component addresses eosinophilic airway inflammation—particularly relevant for COPD patients with blood eosinophil counts above 300 cells/µL—while formoterol reduces dynamic hyperinflation during exertion by sustaining bronchodilation for up to 12 hours. GOLD guidelines support ICS/LABA use in high-exacerbation-risk COPD. Has this combination worked for others managing frequent COPD flare-ups alongside pulmonary rehabilitation?